CAZZANIGA, GIOVANNI
CAZZANIGA, GIOVANNI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia
2025 Saettini, F; Guerra, F; Mauri, M; Salter, C; Adam, M; Adams, D; Baple, E; Barredo, E; Bhatia, S; Borkhardt, A; Brusco, A; Bugarin, C; Chinello, C; Crosby, A; D'Souza, P; Denti, V; Fazio, G; Giuliani, S; Kuehn, H; Amel, H; Elmi, A; Lo, B; Malighetti, F; Mandrile, G; Martín-Nalda, A; Mefford, H; Moratto, D; Emam Mousavi, F; Nelson, Z; Gutiérrez-Solana, L; Macnamara, E; Michaud, V; O'Leary, M; Pagani, L; Pavinato, L; Santamaria, P; Planas-Serra, L; Quadri, M; Raspall-Chaure, M; Rebellato, S; Rosenzweig, S; Roubertie, A; Holzinger, D; Deal, C; Vockley, C; Savino, A; L. Stoddard, J; Uhlig, H; Pujol, A; Magni, F; Paglia, G; Cazzaniga, G; Piazza, R; Barberis, M; Biondi, A
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
2024 van der Velden, V; Dombrink, I; Alten, J; Cazzaniga, G; Clappier, E; Drandi, D; Eckert, C; Fronkova, E; Hancock, J; Kotrova, M; Kraemer, R; Montonen, M; Pfeifer, H; Pott, C; Raff, T; Trautmann, H; Cave, H; Schafer, B; van Dongen, J; Trka, J; Bruggemann, M; van der Velden, V; Raff, T; van Dongen, J
Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing
2024 Hess, J; Kotrova, M; Fricke, B; Songia, S; Rigamonti, S; Cavagna, R; Tosi, M; Paust, N; Langerak, A; Spinelli, O; Cazzaniga, G; Bruggemann, M; Hutzenlaub, T
Cytogenetically Balanced Reciprocal Translocation Could Hide Molecular Genomic Unbalances: Implications for Foetal Phenotype Correlation
2024 Villa, N; Redaelli, S; Farina, S; Sala, E; Crosti, F; Cozzolino, S; Verderio, M; Dalpra, L; Roversi, G; Bentivegna, A; Cazzaniga, G; Lavitrano, M; Conconi, D
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024 Hovorkova, L; Winkowska, L; Skorepova, J; Krumbholz, M; Benesova, A; Polivkova, V; Alten, J; Bardini, M; Meyer, C; Kim, R; Trahair, T; Clappier, E; Chiaretti, S; Henderson, M; Sutton, R; Sramkova, L; Stary, J; Polakova, K; Marschalek, R; Metzler, M; Cazzaniga, G; Cario, G; Trka, J; Zaliova, M; Zuna, J
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation
2024 Bettini, L; Fazio, G; Saitta, C; Piazza, R; Palamini, S; Buracchi, C; Rebellato, S; Santoro, N; Simone, C; Biondi, A; Cazzaniga, G
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 Conter, V; Valsecchi, M; Cario, G; Zimmermann, M; Attarbaschi, A; Stary, J; Niggli, F; Dalla Pozza, L; Elitzur, S; Silvestri, D; Locatelli, F; Moricke, A; Engstler, G; Smisek, P; Bodmer, N; Barbaric, D; Izraeli, S; Rizzari, C; Boos, J; Buldini, B; Zucchetti, M; Von Stackelberg, A; Matteo, C; Lehrnbecher, T; Lanvers-Kaminsky, C; Cazzaniga, G; Gruhn, B; Biondi, A; Schrappe, M
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression
2024 Lopez-Millan, B; Rubio-Gayarre, A; Vinyoles, M; Trincado, J; Fraga, M; Fernandez-Fuentes, N; Guerrero-Murillo, M; Martinez, A; Velasco-Hernandez, T; Falgas, A; Panisello, C; Valcarcel, G; Sardina, J; Lopez-Marti, P; Javierre, B; Del Valle-Perez, B; Garcia de Herreros, A; Locatelli, F; Pieters, R; Bardini, M; Cazzaniga, G; Rodriguez-Manzaneque, J; Hanewald, T; Marschalek, R; Milne, T; Stam, R; Tejedor, J; Menendez, P; Bueno, C
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA
2024 Caye-Eude, A; Fazio, G; Pastorczak, A; Boer, J; Steinemann, D; Ganguli, D; Sonneveld, E; Haslinger, S; D'Andrea, L; Bradtke, J; Lopes, B; Zaliova, M; Escherich, G; König, M; Fortschegger, K; Inthal, A; Stasevich, I; Emerenciano, M; Trka, J; Castillo, L; Parihar, M; Moorman, A; Bergmann, A; den Boer, M; Młynarski, W; Cazzaniga, G; Cavé, H; Nebral, K; Schinnerl, D; Strehl, S
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia
2024 Bardini, M; Fazio, G; Abascal, L; Meyer, C; Maglia, O; Sala, S; Palamini, S; Rebellato, S; Marschalek, R; Rizzari, C; Biondi, A; Cazzaniga, G
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening
2024 Oikonomou, A; Watrin, T; Valsecchi, L; Scharov, K; Savino, A; Schliehe-Diecks, J; Bardini, M; Fazio, G; Bresolin, S; Biondi, A; Borkhardt, A; Bhatia, S; Cazzaniga, G; Palmi, C
The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category
2024 Kotrova, M; Fronkova, E; Svaton, M; Drandi, D; Schön, F; Hoogeveen, P; Hancock, J; Skotnicova, A; Schilhabel, A; Eckert, C; Clappier, E; Cazzaniga, G; Schäfer, B; van Dongen, J; Ritgen, M; Pott, C; van der Velden, V; Trka, J; Brüggemann, M
Antibody Deficiency in Patients with Biallelic KARS1 Mutations
2023 Saettini, F; Guerra, F; Fazio, G; Bugarin, C; Mcmillan, H; Ohtake, A; Ardissone, A; Itoh, M; Giglio, S; Cappuccio, G; Giardino, G; Romano, R; Quadri, M; Gasperini, S; Moratto, D; Chiarini, M; Akira, I; Fukuhara, Y; Hayakawa, I; Okazaki, Y; Mauri, M; Piazza, R; Cazzaniga, G; Biondi, A
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica]
2023 Bettini, L; Lauriola, R; Vendemini, F; Coliva, T; Biondi, A; Cazzaniga, G
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group
2023 Ohki, K; Butler, E; Kiyokawa, N; Hirabayashi, S; Bergmann, A; Moricke, A; Boer, J; Cave, H; Cazzaniga, G; Yeoh, A; Sanada, M; Imamura, T; Inaba, H; Mullighan, C; Loh, M; Noren-Nystrom, U; Shih, L; Zaliova, M; Pui, C; Haas, O; Harrison, C; Moorman, A; Manabe, A
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7)
2023 Saettini, F; Guerra, F; Fazio, G; Bugarin, C; Mcmillan, H; Ohtake, A; Ardissone, A; Itoh, M; Giglio, S; Cappuccio, G; Giardino, G; Romano, R; Quadri, M; Gasperini, S; Moratto, D; Chiarini, M; Ishiguro, A; Fukuhara, Y; Hayakawa, I; Okazaki, Y; Mauri, M; Piazza, R; Cazzaniga, G; Biondi, A
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
2023 Alaggio, R; Amador, C; Anagnostopoulos, I; Attygalle, A; de Oliveira Araujo, I; Berti, E; Bhagat, G; Borges, A; Boyer, D; Calaminici, M; Chadburn, A; Chan, J; Cheuk, W; Chng, W; Choi, J; Chuang, S; Coupland, S; Czader, M; Dave, S; de Jong, D; Di Napoli, A; Du, M; Elenitoba-Johnson, K; Ferry, J; Geyer, J; Gratzinger, D; Guitart, J; Gujral, S; Harris, M; Harrison, C; Hartmann, S; Hochhaus, A; Jansen, P; Karube, K; Kempf, W; Khoury, J; Kimura, H; Klapper, W; Kovach, A; Kumar, S; Lazar, A; Lazzi, S; Leoncini, L; Leung, N; Leventaki, V; Li, X; Lim, M; Liu, W; Louissaint, A; Marcogliese, A; Medeiros, L; Michal, M; Miranda, R; Mitteldorf, C; Montes-Moreno, S; Morice, W; Nardi, V; Naresh, K; Natkunam, Y; Ng, S; Oschlies, I; Ott, G; Parrens, M; Pulitzer, M; Rajkumar, S; Rawstron, A; Rech, K; Rosenwald, A; Said, J; Sarkozy, C; Sayed, S; Saygin, C; Schuh, A; Sewell, W; Siebert, R; Sohani, A; Suzuki, R; Tooze, R; Traverse-Glehen, A; Vega, F; Vergier, B; Wechalekar, A; Wood, B; Xerri, L; Xiao, W; Akinola, N; Akkari, Y; Allende, L; Aozasa, K; Arcaini, L; Ardeshna, K; Asano, N; Attarbaschi, A; Bacon, C; Barrans, S; Batchelor, T; Battistella, M; Baughn, L; Behdad, A; Berentsen, S; Bianchi, G; Bledsoe, J; Borchmann, P; Bower, M; Buldini, B; Burger, J; Burkhardt, B; Cassaday, R; Cazzaniga, G; Cerf-Bensussan, N; Cesarman, E; Chandy, M; Chapman, J; Chapuy, B; Chen, X; Cheng, C; Chiattone, C; Chiorazzi, N; Cook, L; Cooper, W; Corboy, G; Cowan, A; Cozzolino, I; Cree, I; D'Amore, E; Davies, A; Deckert, M; Delabie, J; Demicco, E; Deshpande, V; Diepstra, A; Dierickx, D; Dunleavy, K; Eichhorst, B; Ennishi, D; Fajgenbaum, D; Farinha, P; de Larrea, C; Fisher, K; Fitzgibbon, J; Flanagan, M; Fromm, J; Garcia, J; Geddie, W; Gertz, M; Gopal, A; Gopal, S; Greipp, P; Gru, A; Gupta, R; Hansmann, M; Hebeda, K; Herfarth, K; Herling, M; Hermine, O; Hoang-Xuan, K; Hodge, J; Hu, S; Huang, Y; Hung, Y; Hunger, S; Inaba, H; Inagaki, H; Iqbal, J; Ishitsuka, K; Iwaki, N; Iwatsuki, K; Jain, N; Jeon, Y; Kadin, M; Kaji, S; Kakkar, A; Karadimitris, A; Kataoka, K; Kato, S; Kersten, M; Ketterling, R; Kim, J; Kratz, C; Kridel, R; Kristinsson, S; Kuppers, R; Kuzu, I; Kwong, Y; Lacasce, A; Lamant-Rochaix, L; Lamy, T; Landgren, O; Laskar, S; Laskin, W; Lenz, G; Li, S; Di Li, G; Lin, P; Locatelli, F; Lorsbach, R; Lossos, I; Loughran, T; Macon, W; Maleszewski, J; Malhotra, P; Marafioti, T; Maruyama, D; Marx, A; Mbulaiteye, S; Meignin, V; Mejstrikova, E; Michelow, P; Miettinen, M; Miles, R; Miyoshi, H; Molina, T; Mollejo, M; Momose, S; Mori, T; Morice, W; Nadel, B; Nagai, H; Nagane, M; Nair, R; Nakamura, N; Nakazawa, A; Nasr, S; Nicholson, A; Nicolae, A; Ohgami, R; Oishi, N; Olson, T; Ortonne, N; Paiva, B; Pan-Hammarstrom, Q; Parihar, M; Paulli, M; Petersen, A; Picarsic, J; Pileri, A; Pimpinelli, N; Plaza, J; Rabin, K; Raderer, M; Rai, K; Randen, U; Rao, H; Robson, A; Rochford, R; Rosenquist, R; Rossi, D; Rossi, E; Rule, S; Rymkiewicz, G; Sabattini, E; Saha, V; Sakata-Yanagimoto, M; Sander, C; Sangueza, J; Sangueza, O; Santucci, M; Sato, Y; Satou, A; Schafernak, K; Schmitt, F; Semenzato, G; Sengar, M; Shanafelt, T; Shimada, K; Slack, G; Slager, S; Soffietti, R; Solomon, D; Stamatopoulos, K; Steidl, C; Stilgenbauer, S; Sukswai, N; Takeuchi, K; Tallini, G; Tamaru, J; Tan, S; Tembhare, P; Tiacci, E; Tokura, Y; Tournilhac, O; Treon, S; Truemper, L; Tsukasaki, K; van Rhee, F; Varghese, A; Vermeer, M; Vielh, P; Walker, B; Wang, M; Wang, H; Wang, Z; Watanabe, T; Weigert, O; Weinstock, D; Whittaker, S; Willemze, R; Woessmann, W; Wu, C; Yamaguchi, M; Yamamoto, H; Yamashita, D; Yang, S; Yang, D; Yasuda, T; Yin, W; Zen, Y; Zhao, S; Zhao, W
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
2023 Hunger, S; Tran, T; Saha, V; Devidas, M; Valsecchi, M; Gastier-Foster, J; Cazzaniga, G; Reshmi, S; Borowitz, M; Moorman, A; Heerema, N; Carroll, A; Martin-Regueira, P; Loh, M; Raetz, E; Schultz, K; Slayton, W; Cario, G; Schrappe, M; Silverman, L; Biondi, A